NSW Tuberculosis Surveillance Report 2024: Outcomes

​​​​​​​​​​​​​ On this page

  1. Outcomes for both multidrug-resistant (MDR) and non-MDR tuberculosis cases in NSW, 2024
  2. Contact investigation outcomes from tuberculosis pulmonary smear positive cases diagnosed in NSW, 2024

Outcomes for both multidrug-resistant (MDR) and non-MDR tuberculosis cases in ​​​NSW, 2023

The majority of TB cases successfully completed TB treatment in 2023 (90%). The treatment outcome is unable to be assessed when people transfer overseas (4% of cases), and a small number of cases die from causes not related to TB while on treatment (3% of cases).

Treatment outcomeNon-MDR casesMDR cases
Completed treatment449 (89%)11 (92%)
Defaulted11 (2%)0 (0%)
Treatment failure0 (0%)0 (0%)
Death related​ to TB8 (2%)0 (0%)
Died of other or unknown causes17 (3%) 1 (8%)
Transferred overseas to complete treatment20 (4%)0 (0%)
Remains on extensive treatment0 (0%)0 (0%)
Total506​​ (100%)
12 (100%)

Cont​​act investigation outcomes from TB pulmonary smear positive cases diagnosed in NSW, 2024​​​​1 ​

There were 874 contacts identified in NSW in 2024 from TB pulmonary smear positive cases, 61% of those completed contact screening for TB.

Notes

  1. This reports on contacts tracing on the most infectious cases. More contact tracing was done but it is not reported here​​.​​

  2. Data for this report was extracted from Notifiable Conditions Records for Epidemiology and Surveillance, NSW Ministry of Health on 11 June 2025.

​
Current as at: Wednesday 13 August 2025
Contact page owner: Communicable Diseases